Cargando…
Doxycycline for Sexually Transmitted Infection Prevention: Evolving Evidence and Implementation Perspectives
Editorial for Sexually Transmitted Diseases (STD20–495): Interest, concerns, and attitudes among men who have sex with men and healthcare providers toward prophylactic use of doxycycline against Chlamydia trachomatis infections and syphilis.
Autores principales: | Celum, Connie, Luetkemeyer, Anne F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/ https://www.ncbi.nlm.nih.gov/pubmed/34117188 http://dx.doi.org/10.1097/OLQ.0000000000001501 |
Ejemplares similares
-
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections
por: Grant, Juliana S, et al.
Publicado: (2020) -
Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa
por: Peters, Remco P.H., et al.
Publicado: (2023) -
BASHH updated position statement on doxycycline as prophylaxis for sexually transmitted infections
por: Kohli, Manik, et al.
Publicado: (2022) -
Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial
por: Stewart, Jenell, et al.
Publicado: (2022) -
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections
por: Kong, Fabian Yuh Shiong, et al.
Publicado: (2023)